Inflazyme gets WHO grant for African tuberculosis (TB) trial
This article was originally published in Clinica
Executive Summary
Inflazyme Pharmaceuticals (Canada) has been awarded a WHO research grant to test its TB kit in Uganda. The trial will be carried out by Makene University in Uganda and Cape Western Reserve University, Ohio, US.